Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $3.358B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INVITAE CORP | 12,203,669 | $466M | 13.9% | $2864.61 | — | COM | 46185L103 |
| EXAS | EXACT SCIENCES CORP | 2,360,186 | $311M | 9.3% | $126.85 | +7.9% | COM | 30063P105 |
| FATE | FATE THERAPEUTICS INC | 3,400,000 | $280M | 8.3% | $17.49 | +447.7% | COM | 31189P102 |
| BLFS | BIOLIFE SOLUTIONS INC | 7,440,107 | $268M | 8.0% | $19.73 | +100.4% | COM NEW | 09062W204 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 5,000,000 | $167M | 5.0% | $6.88 | +408.7% | COM | 69404D108 |
| — | BLUEPRINT MEDICINES CORP | 1,550,000 | $151M | 4.5% | $5615.52 | — | COM | 09627Y109 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 880,000 | $124M | 3.7% | $106.09 | +41.9% | COM | 02043Q107 |
| TWST | TWIST BIOSCIENCE CORP | 1,000,000 | $124M | 3.7% | $26.75 | +467.6% | COM | 90184D100 |
| RLAY | RELAY THERAPEUTICS INC | 3,375,058 | $117M | 3.5% | $38.13 | +13.8% | COM | 75943R102 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,165,000 | $112M | 3.3% | $45.91 | +7.9% | COM | 00847X104 |
| CDXS | CODEXIS INC | 4,330,000 | $99.11M | 3.0% | $14.14 | +65.4% | COM | 192005106 |
| DNLI | DENALI THERAPEUTICS INC | 1,610,000 | $91.93M | 2.7% | $27.89 | +140.0% | COM | 24823R105 |
| DMTKQ | DERMTECH INC | 1,745,000 | $88.63M | 2.6% | $20.25 | — | COM | 24984K105 |
| RVMD | REVOLUTION MEDICINES INC | 1,844,535 | $84.63M | 2.5% | $29.67 | +51.1% | COM | 76155X100 |
| CDNA | CAREDX INC | 1,193,335 | $81.25M | 2.4% | $24.07 | +222.6% | COM | 14167L103 |
| BEAM | BEAM THERAPEUTICS INC | 818,820 | $65.54M | 2.0% | $69.31 | +37.2% | COM | 07373V105 |
| ONC | BEIGENE LTD | 150,000 | $52.21M | 1.6% | $188.40 | — | SPONSORED ADR | 07725L102 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 1,150,000 | $46.3M | 1.4% | $43.80 | +23.6% | COM | 00650F109 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,300,000 | $45.89M | 1.4% | $31.13 | +8.4% | COM | 019770106 |
| — | GENERATION BIO CO | 1,611,214 | $45.85M | 1.4% | $21.00 | — | COM | 37148K100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 995,354 | $43.18M | 1.3% | $41.93 | +5.6% | COM | 35104E100 |
| — | CONSTELLATION PHARMCETICLS I | 1,800,000 | $42.1M | 1.3% | $16.45 | — | COM | 210373106 |
| SRPT | SAREPTA THERAPEUTICS INC | 550,000 | $40.99M | 1.2% | $120.70 | -23.6% | COM | 803607100 |
| — | MAGENTA THERAPEUTICS INC | 3,346,034 | $39.62M | 1.2% | $1663.66 | — | COM | 55910K108 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 900,000 | $36.67M | 1.1% | $40.68 | — | COM | 37890U108 |
| ALEC | ALECTOR INC | 1,650,000 | $33.23M | 1.0% | $17.70 | +1.3% | COM | 014442107 |
| CRSP | CRISPR THERAPEUTICS AG | 266,430 | $32.46M | 1.0% | $51.63 | +192.4% | NAMEN AKT | H17182108 |
| ZLAB | ZAI LAB LTD | 190,000 | $25.35M | 0.8% | $51.48 | — | ADR | 98887Q104 |
| — | ORCHARD THERAPEUTICS PLC | 3,215,434 | $23.34M | 0.7% | $7.26 | — | ADS | 68570P101 |
| — | BURNING ROCK BIOTECH LTD | 847,150 | $22.8M | 0.7% | $26.82 | — | SPONSORED ADR | 12233L107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,000,000 | $22.36M | 0.7% | $21.76 | +3.8% | COM | 87164F105 |
| — | ADVERUM BIOTECHNOLOGIES INC | 2,211,622 | $21.81M | 0.6% | $12.41 | — | COM | 00773U108 |
| MASS | 908 DEVICES INC | 406,502 | $19.71M | 0.6% | $58.41 | -2.2% | COM | 65443P102 |
| — | KRONOS BIO INC | 583,436 | $17.08M | 0.5% | $29.87 | — | COM | 50107A104 |
| TSHA | TAYSHA GENE THERAPIES INC | 820,440 | $16.66M | 0.5% | $23.52 | +15.1% | COM SHS | 877619106 |
| ORIC | ORIC PHARMACEUTICALS INC | 601,515 | $14.74M | 0.4% | $30.04 | +5.2% | COM | 68622P109 |
| FULC | FULCRUM THERAPEUTICS INC | 1,241,176 | $14.62M | 0.4% | $11.41 | +8.3% | COM | 359616109 |
| — | DECIBEL THERAPEUTICS INC | 1,146,421 | $13.02M | 0.4% | $11.36 | — | COM | 24343R106 |
| — | BERKELEY LTS INC | 200,000 | $10.05M | 0.3% | $76.36 | — | COM | 084310101 |
| DYN | DYNE THERAPEUTICS INC | 610,000 | $9.473M | 0.3% | $20.94 | -7.6% | COM | 26818M108 |
| SEER | SEER INC | 150,000 | $7.503M | 0.2% | $63.62 | -8.0% | COM CL A | 81578P106 |
| — | TURNING POINT THERAPEUTICS I | 75,000 | $7.094M | 0.2% | $40080.00 | — | COM | 90041T108 |
| SGMO | SANGAMO THERAPEUTICS INC | 550,000 | $6.892M | 0.2% | $8.80 | +53.2% | COM | 800677106 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 726,511 | $5.492M | 0.2% | $11.28 | 0.0% | COM CL A | 18914F103 |
| STOK | STOKE THERAPEUTICS INC | 120,000 | $4.661M | 0.1% | $27.21 | +109.2% | COM | 86150R107 |
| FHTX | FOGHORN THERAPEUTICS INC | 216,216 | $2.85M | 0.1% | $19.16 | -14.5% | COM | 344174107 |
| SANA | SANA BIOTECHNOLOGY INC | 60,000 | $2.008M | 0.1% | $32.56 | 0.0% | COM | 799566104 |
| — | CODIAK BIOSCIENCES INC | 76,688 | $1.156M | 0.0% | $32.30 | — | COM | 192010106 |